LAURA ANDERSON: Open Payments
NPI 1699068114 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,533 in 92 payments from 15 companies in 2025. Trend: 2023 $1,257 · 2024 $1,588 · 2025 $1,533
Food & beverage: $1,533
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $484 |
| Janssen Biotech, Inc. | 13 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $169 |
| Aimmune Therapeutics, Inc. | 9 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| Phathom Pharmaceuticals, Inc. | 12 | $77 |
| Lilly USA, LLC | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Madrigal Pharmaceuticals | 2 | $55 |
| GENZYME CORPORATION | 1 | $22 |
Products named: RINVOQ, TREMFYA, ENTYVIO, ZENPEP, XIFAXAN, DUPIXENT, CREON, LINZESS.
Industry payments across GA — which companies pay providers there.
